[go: up one dir, main page]

EP1218030A4 - Methoden und zusammensetzungen zur behandlung und prävention von transplantatabstossung durch verwendung von hitzeschockproteinen - Google Patents

Methoden und zusammensetzungen zur behandlung und prävention von transplantatabstossung durch verwendung von hitzeschockproteinen

Info

Publication number
EP1218030A4
EP1218030A4 EP00961701A EP00961701A EP1218030A4 EP 1218030 A4 EP1218030 A4 EP 1218030A4 EP 00961701 A EP00961701 A EP 00961701A EP 00961701 A EP00961701 A EP 00961701A EP 1218030 A4 EP1218030 A4 EP 1218030A4
Authority
EP
European Patent Office
Prior art keywords
prevention
compositions
treatment
methods
thermal shock
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP00961701A
Other languages
English (en)
French (fr)
Other versions
EP1218030A1 (de
Inventor
Pramod K Srivastava
Rajiv Y Chandawarkar
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fordham University
Original Assignee
Fordham University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fordham University filed Critical Fordham University
Publication of EP1218030A1 publication Critical patent/EP1218030A1/de
Publication of EP1218030A4 publication Critical patent/EP1218030A4/de
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/001—Preparations to induce tolerance to non-self, e.g. prior to transplantation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A61K2039/6043—Heat shock proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/62—Medicinal preparations containing antigens or antibodies characterised by the link between antigen and carrier
    • A61K2039/622—Medicinal preparations containing antigens or antibodies characterised by the link between antigen and carrier non-covalent binding

Landscapes

  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Transplantation (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
EP00961701A 1999-09-10 2000-09-08 Methoden und zusammensetzungen zur behandlung und prävention von transplantatabstossung durch verwendung von hitzeschockproteinen Withdrawn EP1218030A4 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US39365299A 1999-09-10 1999-09-10
US393652 1999-09-10
PCT/US2000/024711 WO2001017554A1 (en) 1999-09-10 2000-09-08 Methods and compositions for the treatment and prevention of graft rejection using heat shock proteins

Publications (2)

Publication Number Publication Date
EP1218030A1 EP1218030A1 (de) 2002-07-03
EP1218030A4 true EP1218030A4 (de) 2004-09-15

Family

ID=23555669

Family Applications (1)

Application Number Title Priority Date Filing Date
EP00961701A Withdrawn EP1218030A4 (de) 1999-09-10 2000-09-08 Methoden und zusammensetzungen zur behandlung und prävention von transplantatabstossung durch verwendung von hitzeschockproteinen

Country Status (4)

Country Link
EP (1) EP1218030A4 (de)
AU (1) AU7361900A (de)
CA (1) CA2383213A1 (de)
WO (1) WO2001017554A1 (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6495347B1 (en) 1999-07-08 2002-12-17 Stressgen Biotechnologies Corporation Induction of a Th1-like response in vitro
PL359930A1 (en) 2000-06-26 2004-09-06 Stressgen Biotechnologies Corporation Human papilloma virus treatment
EP1357940A4 (de) 2001-02-05 2004-03-17 Stressgen Biotechnologies Corp Hepatitis?b?virustherapie
WO2003096967A2 (en) 2002-05-21 2003-11-27 Yeda Research And Development Co. Ltd. Dna vaccines encoding heat shock proteins
AU2002952492A0 (en) 2002-11-06 2002-11-21 Cbio Limited Chaperonin 10 immunosuppression
US7745578B2 (en) * 2003-07-07 2010-06-29 The General Hospital Corporation Fugetactic proteins, compositions and methods of use
EP2428801B1 (de) 2006-03-14 2014-05-07 Oregon Health and Science University Methoden zur Detektion einer Mycobakterium tuberculosis Infektion
EP2918598B1 (de) 2007-02-28 2019-01-30 The Govt. Of U.S.A. As Represented By The Secretary Of The Department Of Health And Human Services Brachyurie-Polypeptide und Verwendungsverfahren
CA3004867C (en) 2008-06-26 2020-09-15 Orphazyme Aps Use of hsp70 as a regulator of enzymatic activity
WO2010099472A2 (en) 2009-02-27 2010-09-02 The U.S.A. Of America, As Represented By The Secretary, Department Of Health And Human Services Spanx-b polypeptides and their use
CN102462841A (zh) * 2010-11-09 2012-05-23 中国科学院微生物研究所 一种促进gp96蛋白的免疫活性的方法及其应用
JP2013544263A (ja) 2010-11-30 2013-12-12 オルファザイム エーピーエス Ｈｓｐ７０の細胞内活性を上昇させる方法
EP2895191B1 (de) 2012-09-14 2019-06-05 The U.S.A. as represented by the Secretary, Department of Health and Human Services Brachyury-protein, adenovirale vektoren zur codierung von brachyury-protein und deren verwendung
BR102014002362A8 (pt) 2014-01-30 2018-04-17 Uniao Brasileira De Educacao E Assistencia Mantenedora Da Puc Rs método de imunomodulação e/ou preservação de órgãos ex-vivo, composições, processo e usos
JP6678676B2 (ja) 2014-09-15 2020-04-08 オーファザイム エー／エス アリモクロモル製剤
EP4137150A1 (de) 2015-08-03 2023-02-22 The United States of America, as represented by the Secretary, Department of Health and Human Services Brachyury-deletionsmutanten, nichthefevektoren zur codierung von brachyury-deletionsmutanten und verwendung davon
EP3442530A1 (de) 2016-04-13 2019-02-20 Orphazyme A/S Hitzeschockproteinen und cholesterinhomöostase
PT3448382T (pt) 2016-04-29 2020-11-20 Orphazyme As C/O Cobis As Arimoclomol para o tratamento de distúrbios associados à glucocerebrosidase
IL303026A (en) 2020-11-19 2023-07-01 Zevra Denmark As Processes for preparing arimoclomol citrate and intermediates thereof

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5891653A (en) * 1995-12-29 1999-04-06 Attfield; Derrick Cecil Method of suppressing graft rejection by means of stress proteins

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5891653A (en) * 1995-12-29 1999-04-06 Attfield; Derrick Cecil Method of suppressing graft rejection by means of stress proteins

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
DUQUESNOY R J ET AL: "Evidence for heat shock protein immunity in a rat cardiac allograft model of chronic rejection", TRANSPLANTATION 15 JAN 1999 UNITED STATES, vol. 67, no. 1, 15 January 1999 (1999-01-15), pages 156 - 164, XP008032921, ISSN: 0041-1337 *
QIAN J ET AL: "Expression of stress proteins and lymphocyte reactivity in heterotopic cardiac allografts undergoing cellular rejection", TRANSPLANT IMMUNOLOGY 1995 UNITED KINGDOM, vol. 3, no. 2, 1995, pages 114 - 123, XP002288908, ISSN: 0966-3274 *
RIZZO MONICA ET AL: "Increased expression of HDJ-2 (heat shock protein 40) and heat shock protein 70 in biopsy specimens of transplanted human lungs", JOURNAL OF HEART AND LUNG TRANSPLANTATION, vol. 17, no. 3, March 1998 (1998-03-01), pages 241 - 249, XP008032559, ISSN: 1053-2498 *
See also references of WO0117554A1 *

Also Published As

Publication number Publication date
AU7361900A (en) 2001-04-10
WO2001017554A9 (en) 2002-09-26
CA2383213A1 (en) 2001-03-15
WO2001017554A1 (en) 2001-03-15
EP1218030A1 (de) 2002-07-03

Similar Documents

Publication Publication Date Title
EP1218030A4 (de) Methoden und zusammensetzungen zur behandlung und prävention von transplantatabstossung durch verwendung von hitzeschockproteinen
MA27374A1 (fr) Ester de 2'-c-methyl-3'-o-l-valine et de ribofuranosyl cytidine pour le traitement des infections des flaviviridae
EP1001807A4 (de) Adoptive immunotherapie unter verwendung von hitze/stress protein-peptid komplexen zur vorbeugung/behandlung von krebs oder infektionskrankheiten
EP1446114A4 (de) Zusammensetzungen und verfahren zur behandlung von osteoporose
DK0971735T3 (da) Fremgangsmåder og præparater til behandling af inflammatorisk tarmsygdom
FR12C0077I2 (fr) Composition pour le traitement des condylomes génitaux
NO20035611D0 (no) Sammensetning og fremgangsmåte for kontroll ved behandling av hydrokarbon
EP1320124A4 (de) Verfahren zur bestimmung von parametern einer thermischen behandlung
NO20000085D0 (no) Forbedrede metoder og sammensetninger for behandling av erektil dysfunksjon hos menn
DE60130043D1 (de) Grundierungszusammensetzung und Beschichtungsverfahren
NO20003096L (no) Sammensetninger og fremgangsmÕter for behandling av ADD
EP1560593A4 (de) Neue zusammensetzung und verfahren zur behandlung von immunerkrankungen
NO20040873L (no) Fremgangsmate og anordning for sammensetting av gjenfestbare absorberende klesplagg
DE69906754D1 (de) Einbringung von rauchmodifizierenden mitteln in rauchartikeln
NO20013665D0 (no) Kaliumsalt av (S)-omeprazol
NO20041004L (no) Fremgangsmate og anordning for sammensetting av gjenfestbare absorberende klesplagg
EP1161255A4 (de) Verfahren und mittel zur behandlung erektiler dysfunktion
EP1359885A4 (de) Nos-hemmer zur behandlung von falten
IL155174A0 (en) Methods and compositions for the treatment of inflammatory diseases
FR2738328B1 (fr) Blocs protecteurs refractaires et structure de paroi protectrice de chaudiere les utilisant
MA25268A1 (fr) Composition non-collante de confiserie molle et methodes pour la fabriquer
DZ3225A1 (fr) Methode et compositions pour le traitement des maladies pulmonaires
NO20001758D0 (no) Fremgangsmåter og blandinger for behandling av leddgikt
EP1456377A4 (de) Syn3-zusammensetzungen und verfahren
DE60225446D1 (de) Flammgeschützte zusammensetzung und artikel

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20020409

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

AX Request for extension of the european patent

Free format text: AL;LT;LV;MK;RO;SI

RIC1 Information provided on ipc code assigned before grant

Ipc: 7A 61K 39/00 B

Ipc: 7A 61K 39/385 A

Ipc: 7A 61K 45/00 B

Ipc: 7A 01N 37/18 B

Ipc: 7C 07K 1/00 B

Ipc: 7C 07K 2/00 B

A4 Supplementary search report drawn up and despatched

Effective date: 20040729

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20060928